Signal transduction during platelet plug formation

Platelets, Second Edition

Volumn , Issue , 2006, Pages 319-346

  Brass, Lawrence F ^a   Stalker, Timothy J ^a   Zhu, Li ^a   Woulfe, Donna S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34347347129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50778-3     Document Type: Chapter

References (242)

1. K. Simons and E. Ikonen (1997) Functional rafts in cell membranes. Nature 387 569-572.
2. P.B. Maguire, M. Foy and D.J. Fitzgerald (2005) Using proteomics to identify potential therapeutic targets in platelets. Biochem Soc Trans 33 409-412.
3. J.A. Lopez, I. del Conde and C.N. Shrimpton (2005) Receptors, rafts, and microvesicles in thrombosis and infl ammation. J Thromb Haexmost 3 1737-1744.
4. T.M. Quinton, S. Kim, J. Jin, et al. (2005) Lipid rafts are required in Galpha (i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J Thromb Haemost 3 1036-1041.
5. D. Locke, H. Chen, Y. Liu, et al. (2002) Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J Biol Chem 277 18801-18809.
6. J.F. Mustard and M.A. Packham (1970) Factors infl uencing platelet function: Adhesion, release, and aggregation. Pharm Rev 22 97-187.
7. S. Falati, Q. Liu, P. Gross, et al. (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 1585-1598.
8. P.L. Gross, B.C. Furie, G. Merrill-Skoloff, et al. (2005) Leukocyte versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol 78 1318-1326.
9. C.I. Del Conde I., C.N. Shrimpton, P. Thiagarajan, et al. (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 1604-1611.
10. S.A. Santoro (1986) Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 46 913-920.
11. L.F. Brass and H.B. Bensusan (1974) The role of collagen quaternary strucuture in the platelet: Collagen interaction. J Clin Invest 54 1480-1487.
12. L.F. Brass, D. Faile and H.B. Bensusan (1976) Direct measurement of the platelet: Collagen interaction by affinity chromatography on collagen/Sepharose. J Lab Clin Med 87 525-534.
13. J.M. Clemetson, J. Polgar, E. Magnenat, et al. (1999) The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 274 29019-29024.
14. S. Massberg, M. Gawaz, S. Gruner, et al. (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197 41-49.
15. K. Kato, T. Kanaji, S. Russell, et al. (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102 1701-1707.
16. A. Poole, J.M. Gibbins, M. Turner, et al. (1997) The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16 2333-2341.
17. B. Nieswandt, C. Brakebusch, W. Bergmeier, et al. (2001) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 20 2120-2130.
18. H.K. Nieuwenhuis, J.W.N. Akkerman, W.P.M. Houdijk, et al. (1985) Human blood platelets showing no response to collagen fail to express glycoprotein Ia. Nature 318 470-472.
19. J.J. Sixma, G.H. Van Zanten, E.G. Huizinga, et al. (1997) Platelet adhesion to collagen: An update. Thromb Haemost 78 434-438.
20. M.J. Kuijpers, V. Schulte, W. Bergmeier, et al. (2003) Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in fl owing whole blood ex vivo. FASEB J 17 685-687.
21. W.S. Nesbitt, S. Giuliano, S. Kulkarni, et al. (2003) Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol 160 1151-1161.
22. S. Kulkarni, W.S. Nesbitt, S.M. Dopheide, et al. (2004) Techniques to examine platelet adhesive interactions under fl ow. Methods Mol Biol 272 165-186.
23. H.E. Hamm (2001) How activated receptors couple to G proteins. Proc Natl Acad Sci USA 98 4819-4821.
24. M. Bünemann, K.B. Lee, R. Pals-Rylaarsdam, et al. (1999) Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu Rev Physiol 61 169-192.
25. R.B. Penn, A.N. Pronin and J.L. Benovic (2000) Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 10 81-89.
26. K. Palczewski, T. Kumasaka, T. Hori, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 739-745.
27. D.G. Lambright, J. Sondek, A. Bohm, et al. (1996) The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379 311-319.
28. C.E. Ford, N.P. Skiba, H.S. Bae, et al. (1998) Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280 1271-1274.
29. E.M. Ross and T.M. Wilkie (2000) GTPase-activating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69 795-827.
30. J.R. Crittenden, W. Bergmeier, Y. Zhang, et al. (2004) CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nature Med 10 982-986.
31. A. Bertoni, S. Tadokoro, K. Eto, et al. (2002) Relationships between Rap1b, affinity modulation of integrin αIIbβ3, and the actin cytoskeleton. J Biol Chem 277 25715-25721.
32. M. Chrzanowska-Wodnicka, S.S. Smyth, S.M. Schoenwaelder, et al. (2005) Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 115 680-687.
33. D. Woulfe, H. Jiang, R. Mortensen, et al. (2002) Activation of Rap1B by Gi family members in platelets. J Biol Chem 277 23382-23390.
34. S.J. Shattil and L.F. Brass (1987) Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 262 992-1000.
35. B. Klages, U. Brandt, M.I. Simon, et al. (1999) Activation of G12/G13 results in shape change and Rho/Rho-kinasemediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144 745-754.
36. S. Offermanns (2001) In vivo functions of heterotrimeric G-proteins: Studies in Galpha-deficient mice. Oncogene 20 1635-1642.
37. S. Fukuhara, H. Chikumi and J.S. Gutkind (2001) RGScontaining RhoGEFs: The missing link between transforming G proteins and Rho? Oncogene 20 1661-1668.
38. S. Offermanns, C.F. Toombs, Y.-H. Hu, et al. (1997) Defective platelet activation in Galphaq-deficient mice. Nature 389 183-186.
39. A. Moers, B. Nieswandt, S. Massberg, et al. (2003) G (13) is an essential mediator of platelet activation in hemostasis and thrombosis. Nature Med 9 1418-1422.
40. A. Moers, N. Wettschureck, S. Gruner, et al. (2004) Unresponsiveness of platelets lacking both Galpha (q) and Galpha (13). Implications for collagen-induced platelet activation. J Biol Chem 279 45354-45359.
41. A. Moers, B. Nieswandt, S. Massberg, et al. (2003) G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nature Med 9 1418-1422.
42. J.I. Wilde, M. Retzer, W. Siess, et al. (2000) ADP-induced platelet shape change: An investigation of the signalling pathways involved and their dependence on the method of platelet preparation. Platelets 11 286-295.
43. D. Pandey, P. Goyal, J.R. Bamburg, et al. (2005) Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets. Blood 107 575-583.
44. R.J. Haslam, N.T. Dickinson and E.K. Jang (1999) Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 82 412-423.
45. I.M.L.W. Keularts, R.M.A. Van Gorp, M.A.H. Feijge, et al. (2000) alpha2A-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem 275 1763-1772.
46. J. Yang, J. Wu, H. Jiang, et al. (2002) Signaling through Gi family members in platelets —Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 277 46035-46042.
47. T. Murata, F. Ushikubi, T. Matsuoka, et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388 678-682.
48. J.L. Daniel, C. Dangelmaier, J.G. Jin, et al. (1999) Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 82 1322-1326.
49. D. Woulfe, H. Jiang, A. Morgans, et al. (2004) Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113 441-450.
50. P. Lova, S. Paganini, F. Sinigaglia, et al. (2002) A Gidependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 277 12009-12015.
51. R.T. Dorsam, S. Kim, J.G. Jin, et al. (2002) Coordinated9 signaling through both G12/13 and Gi pathways is sufficient to activate GPIIb/IIIa in human platelets. J Biol Chem 277 47588-47595.
52. S.P. Jackson, C.L. Yap and K.E. Anderson (2004) Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 32 387-392.
53. S.P. Jackson, S.M. Schoenwaelder, I. Goncalves, et al. (2005) PI 3-kinase p110beta: A new target for antithrombotic therapy. Nature Med 11 507-514.
54. E. Hirsch, O. Bosco, P. Tropel, et al. (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15 NIL307-NIL326
55. J. Chen, S. De, D.S. Damron, et al. (2004) Impaired platelet responses to thrombin and collagen in AKT-1-defi-cient mice. Blood 104 1703-1710.
56. J. Chen, P.R. Somanath, O. Razorenova, et al. (2005) Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nature Med 11 1188-1196.
57. J.L. Daniel, C. Dangelmaier, J.G. Jin, et al. (1998) Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273 2024-2029.
58. J.G. Jin, J.L. Daniel and S.P. Kunapuli (1998) Molecular basis for ADP-induced platelet activation II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273 2030-2034.
59. G.J. Fisher, S. Bakshian and J.J. Baldassare (1985) Activation of human platelets by ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phosphatidylinositol-4,5-bisphosphate. Biochem Biophys Res Commun 129 958-964.
60. J.L. Daniel, C.A. Dangelmaier, M. Selak, et al. (1986) ADP stimulates IP3 formation in human platelets. FEBS Lett 206 299-303.
61. C. Léon, B. Hechler, C. Vial, et al. (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403 26-30.
62. G. Hollopeter, H.M. Jantzen, D. Vincent, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409 202-207.
63. F.L. Zhang, L. Luo, E. Gustafson, et al. (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276 8608-8615.
64. J.G. Jin and S.P. Kunapuli (1998) Coactivation of two different G protein-coupled receptors is essential for ADPinduced platelet aggregation. Proc Natl Acad Sci USA 95 8070-8074.
65. A.B. McKenzie, M.P. Mahout-Smith and S.O. Sage (1996) Activation of receptor-operated channels via P2X1 not P2T purinoreceptors in human platelets. J Biol Chem 271 2879-2881.
66. C. Vial, B. Hechler, C. Léon, et al. (1997) Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 78 1500-1504.
67. B. Sun, J. Li, K. Okahara, et al. (1998) P2X1 purinoceptor in human platelets —Molecular cloning and functional characterization after heterologous expression. J Biol Chem 273 11544-11547.
68. M.P. Mahaut-Smith, S.J. Ennion, M.G. Rolf, et al. (2000) ADP is not an agonist at P2X1 receptors: Evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 131 108-114.
69. C.Y. Fung, C.A. Brearley, R.W. Farndale, et al. (2005) A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemost 94 37-40.
70. M.P. Mahaut-Smith, G. Tolhurst and R.J. Evans (2004) Emerging roles for P2X1 receptors in platelet activation. Platelets 15 131-144.
71. B. Hechler, N. Lenain, P. Marchese, et al. (2003) A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 198 661-667.
72. G. Tolhurst, C. Vial, C. Leon, et al. (2005) Interplay between P2Y (1) , P2Y (12) , and P2X (1) receptors in the activation of megakaryocyte cation influx currents by ADP: Evidence that the primary megakaryocyte represents a fully functional model of platelet P2receptor signaling. Blood 106 1644-1651.
73. S. Offermanns, C.F. Toombs, Y.H. Hu, et al. (1997) Defective platelet activation in Galphaq-deficient mice. Nature 389 183-186.
74. C. Soulet, B. Hechler, M.P. Gratacap, et al. (2005) A differential role of the platelet ADP receptors P2Y and P2Y in Rac activation. J Thromb Haemost 3 2296-2306.
75. P.F. Nurden, P. Savi, E. Heilmann, et al. (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 95 1612-1622.
76. C.J. Foster (2001) Molecular Identification and characterization of the platelet ADP receptor targeted by thienopyridine drugs using P2Yac-null mice. J Clin Invest 107 1591-1598.
77. H.-M. Jantzen, D.S. Milstone, L. Gousset, et al. (2001) Impaired activation of murine platelets lacking Galphai2. J Clin Invest 108 477-483.
78. J. Yang, J. Wu, M.A. Kowalska, et al. (2000) Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 97 9984-9989.
79. M. Cattaneo and C. Gachet (1999) ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 19 2281-2285.
80. J.E. Fabre, M.T. Nguyen, A. Latour, et al. (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nature Med 5 1199-1202.
81. C. Léon, B. Hechler, M. Freund, et al. (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 104 1731-1737.
82. B.Z.S. Paul, J.G. Jin and S.P. Kunapuli (1999) Molecular mechanism of thromboxane A2-induced platelet aggregation —Essential role for P2TAC and alpha2A receptors. J Biol Chem 274 29108-29114.
83. J.S. Bennett (2001) Novel platelet inhibitors. Annu Rev Med 52 161-184.
84. A.J. Barr, L.F. Brass and D.R. Manning (1997) Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells: A direct evaluation of selectivity in receptor-G protein coupling. J Biol Chem 272 2223-2229.
85. S. Kim, C. Foster, A. Lecchi, et al. (2002) Protease activated recepton 1 and 4 do not stimulate G (i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independantly of G (i) signaling. Blood 99 3629-3636.
86. T.-K.H. Vu, D.T. Hung, V.I. Wheaton, et al. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 1057-1068.
87. A.J. Connolly, H. Ishihara, M.L. Kahn, et al. (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381 516-519.
88. C.T. Griffin, Y. Srinivasan, Y.W. Zheng, et al. (2001) A role of thrombin receptor signaling in endothelial cells during embryonic development. Science 293 1666-1670.
89. M. Nakanishi-Matsui, Y.W. Zheng, D.J. Sulciner, et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404 609-610.
90. W.-F. Xu, H. Andersen, T.E. Whitmore, et al. (1998) Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95 6642-6646.
91. M.L. Kahn, Y.W. Zheng, W. Huang, et al. (1998) A dual thrombin receptor system for platelet activation. Nature 394 690-694.
92. K. Ishii, R. Gerszten, Y.W. Zheng, et al. (1995) Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3aspartate. J Biol Chem 270 16435-16440.
93. L. Covic, A.L. Gresser and A. Kuliopulos (2000) Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39 5458-5467.
94. M.J. Shapiro, E.J. Weiss, T.R. Faruqi, et al. (2000) Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 275 25216-25221.
95. M.L. Kahn, M. Nakanishi-Matsui, M.J. Shapiro, et al. (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103 879-887.
96. G.R. Sambrano, E.J. Weiss, Y.-W. Zheng, et al. (2001) Role of thrombin signaling in platelets in hemostasis and thrombosis. Nature 413 74-78.
97. J.A. Lopez, R.K. Andrews, V. Afshar-Khargan, et al. (1998) Bernard-Soulier syndrome. Blood 91 4397-4418.
98. R. De Cristofaro, E. De Candia, S. Rutella, et al. (2000) The Asp272-Glu282 region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparincatalyzed inhibition by antithrombin III. J Biol Chem 275 3887-3895.
99. L. De Marco, M. Mazzucato, A. Masotti, et al. (1991) Function of glycoprotein Ibalpha in platelet activation induced by alpha-thrombin. J Biol Chem 266 23776-23783.
100. J.T. Harmon and G.A. Jamieson (1988) Platelet activation by thrombin in the absence of the high affinity thrombin receptor. Biochemistry 27 2151-2157.
101. M. Mazzucato, L. De Marco, A. Masotti, et al. (1998) Characterization of the initial alpha-thrombin interaction with glycoprotein Ibalpha in relation to platelet activation. J Biol Chem 273 1880-1887.
102. E. De Candia, S.W. Hall, S. Rutella, et al. (2001) Binding of thrombin to glycoprotein Ib accelerates hydrolysis of PAR1 on intact platelets. J Biol Chem 276 4692-4698.
103. D. Dörmann, K.J. Clemetson and B.E. Kehrel (2000) The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 96 2469-2478.
104. A.K. Rao, J. Willis, M.A. Kowalska, et al. (1988) Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha2-adrenergic receptor defect. Blood 71 494-501.
105. G. Tamponi, A. Pannocchia, C. Arduino, et al. (1987) Congenital deficiency of alpha2-adrenoreceptors on human platelets: Description of two cases. Thromb Haemost 58 1012-1016.
106. K.D. Newman, L.T. Williams, N.H. Bishopric, et al. (1978) Identification of alpha-adrenergic receptors in human platelets by 3H-dihydroergocryptine binding. J Clin Invest 61 395-402.
107. P. Kaywin, M. McDonough, P.A. Insel, et al. (1978) Platelet function in essential thrombocythemia: Decreased epinephrine responsivenesss associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 299 505-509.
108. H.J. Motulsky and P.A. Insel (1982) [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H] prazosin, [3H]yohimbine, and [3H]rauwolscine. Biochem Pharmacol 31 2591-2597.
109. W. Siess, P.C. Weber and E.G. Lapetina (1984) Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem 259 8286-8292.
110. A. Williams, M.J. Woolkalis, M. Poncz, et al. (1990) Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes and HEL cells. Blood 76 721-730.
111. P.J. Casey, H.K.W. Fong, M.I. Simon, et al. (1990) Gz, a guanine nucleotide-binding protein with unique biochemical properties. J Biol Chem 265 2383-2390.
112. K.M. Lounsbury, P.J. Casey, L.F. Brass, et al. (1991) Phosphorylation of Gz in human platelets: Selectivity and site of modification. J Biol Chem 266 22051-22056.
113. J. Wang, J.A. Frost and E.M. Ross (1999) Reciprocal signaling between heterotrimeric G proteins and the p21-stimulated protein kinase. J Biol Chem 274 31641-31647.
114. J.M. Gerrard and R.C. Carroll (1981) Stimulation of protein phosphorylation by arachidonic acid and endoperoxide analog. Prostaglandins 22 81-94.
115. G.A. Fitz Gerald (1991) Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 68 11B-15B.
116. L.F. Brass, C.C. Shaller and E.J. Belmonte (1987) Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. J Clin Invest 79 1269-1275.
117. T. Hirata, F. Ushikubi, A. Kakizuka, et al. (1996) Two thromboxane A2 receptor isoforms in human platelets —Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 97 949-956.
118. I. Knezevic, C. Borg and B.G.C. Le Breton G.C. (1993) Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors. J Biol Chem 268 26011-26017.
119. S. Offermanns, K.-L. Laugwitz, K. Spicher, et al. (1994) G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91 504-508.
120. Y. Djellas, J.M. Manganello, K. Antonakis, et al. (1999) Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors. J Biol Chem 274 14325-14330.
121. Y. Gao, S. Tang, S. Zhou, et al. (2001) The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296 426-433.
122. D.W. Thomas, R.B. Mannon, P.J. Mannon, et al. (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102 1994-2001.
123. W. Higuchi, I. Fuse, A. Hattori, et al. (1999) Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity. Thromb Haemost 82 1528-1531.
124. M. Humbert, P. Nurden, C. Bihour, et al. (1996) Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol 16 1532-1543.
125. J.G. White (1972) Interaction of membrane systems in blood platelets. Am J Pathol 66 295-312.
126. J.G. White (1988) Platelet membrane ultrastructure and its changes during platelet activation. Prog Clin Biol Res 283 1-32.
127. R.J. Skaer, J.P. Emmines and H.B. Skaer (1979) The fi ne structure of cell contacts in platelet aggregation. J Ultrastruct Res 69 28-42.
128. J.W. Elrod, J.H. Park, T. Oshima, et al. (2003) Expression of junctional proteins in human platelets. Platelets 14 247-251.
129. D.J. Tschumperlin, G. Dai, I.V. Maly, et al. (2004) Mechanotransduction through growth-factor shedding into the extracellular space. Nature 429 83-86.
130. S.J. Shattil and P.J. Newman (2004) Integrins: Dynamic scaffolds for adhesion and signaling in platelets. Blood 104 1606-1615.
131. S.J. Shattil, T. O'Toole, M. Eigenthaler, et al. (1995) beta3-Endonexin, a novel polypeptide that interacts specificsally with the cytoplasmic tail of the integrin beta3 subunit. J Cell Biol 131 807-816.
132. U.P. Naik, P.M. Patel and L.V. Parise (1997) Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain. J Biol Chem 272 4651-4654.
133. D.A. Calderwood, R. Zent, R. Grant, et al. (1999) The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274 28071-28074.
134. A.L. Jenkins, L. Nannizzi-Alaimo, D. Silver, et al. (1998) Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem 273 13878-13885.
135. K.J. Cowan, D.A. Law and D.R. Phillips (2000) Identifi-cation of Shc as the primary protein binding to the tyrosinephosphorylated beta3 subunit of alphaIIbbeta3 during outside-in integrin platelet signaling. J Biol Chem 275 36423-36429.
136. E.G. Arias-Salgado, S. Lizano, S. Sarkar, et al. (2003) Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA 100 13298-13302.
137. J. Gao, K.E. Zoller, M.H. Ginsberg, et al. (1997) Regulation of the pp72syk protein tyrosine kinase by platelet integrin alphaIIbbeta3. EMBO J 16 6414-6425.
138. D.G. Woodside, A. Obergfell, L. Leng, et al. (2001) Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr Biol 11 1799-1804.
139. D.A. Calderwood and M.H. Ginsberg (2003) Talin forges the links between integrins and actin. Nature Cell Biol 5 694-697.
140. B.I. Ratnikov, A.W. Partridge and M.H. Ginsberg (2005) Integrin activation by talin. J Thromb Haemost 3 1783-1790.
141. S. Tadokoro, S.J. Shattil, K. Eto, et al. (2003) Talin binding to integrin beta tails: A fi nal common step in integrin activation. Science 302 103-106.
142. T.M. Leisner, M. Liu, Z.M. Jaffer, et al. (2005) Essential role of CIB1 in regulating PAK1 activation and cell migration. J Cell Biol 170 465-476.
143. D.R. Philips, K.S.S. Prasad, J. Manganello, et al. (2001) Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 13 546-554.
144. D.R. Phillips, L. Nannizzi-Alamio and K.S.S. Prasad (2001) beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 86 246-258.
145. D.A. Law, F.R. DeGuzman, P. Heiser, et al. (1999) Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature 401 808-811.
146. B. Payrastre, K. Missy, C. Trumel, et al. (2000) The integrin alphaIIb/beta3 in human platelet signal transduction. Biochem Pharmacol 60 1069-1074.
147. A. Obergfell, K. Eto, A. Mocsai, et al. (2002) Coordinate interactions of Csk, Src and Syk kinases with alphaIIbbeta3 initiate integrin signaling to the cytoskeleton. J Cell Biol 157 265-275.
148. P.J. Newman and D.K. Newman (2003) Signal transduction pathways mediated by PECAM-1: New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23 953-964.
149. P.J. Newman (1999) Switched at birth: A new family for PECAM-1. J Clin Invest 103 5-9.
150. S. Patil, D.K. Newman and P.J. Newman (2001) Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 97 1727-1732.
151. K.L. Jones, S.C. Hughan, S.M. Dopheide, et al. (2001) Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 98 1456-1463.
152. S. Falati, S. Patil, P.L. Gross, et al. (2006) Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 107 535-541.
153. W.A. Muller (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24 327-334.
154. G. Bazzoni (2003) The JAM family of junctional adhesio molecules. Curr Opin Cell Biol 15 525-530.
155. G. Ostermann, K.S. Weber, A. Zernecke, et al. (2002) JAM-1 is a ligand of the beta (2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunol 3 151-158.
156. S. Santoso, U.J. Sachs, H. Kroll, et al. (2002) The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 196 679-691.
157. E. Kornecki, B. Walkowiak, U.P. Naik, et al. (1990) Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 265 10042-10048.
158. U.P. Naik, Y.H. Ehrlich and E. Kornecki (1995) Mechanisms of platelet activation by a stimulatory antibody: Crosslinking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. Biochem J 310 155-162. (Pt 1)
159. A. Babinska, M.H. Kedees, H. Athar, et al. (2002) F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: Role in inflammatory thrombosis. Thromb Haemost 88 843-850.
160. K. Hirata, T. Ishida, K. Penta, et al. (2001) Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 276 16223-16231.
161. I. Nasdala, K. Wolburg-Buchholz, H. Wolburg, et al. (2002) A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem 277 16294-16303.
162. J.L. Scott, S.M. Dunn, B. Jin, et al. (1989) Characterization of a novel membrane glycoprotein involved in platelet activation. J Biol Chem 264 13475-13482.
163. H. Kojima, H. Kanada, S. Shimizu, et al. (2003) CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem 278 36748-36753.
164. C. Bottino, R. Castriconi, D. Pende, et al. (2003) Identifi-cation of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198 557-567.
165. N. Nanda, P. Andre, M. Bao, et al. (2005) Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 106 3028-3034.
166. S.W. Krause, M. Rehli, S. Heinz, et al. (2000) Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: Identity with CD84. Biochem J 346 729-736.
167. M. Martin, X. Romero, M.A. de la Fuente, et al. (2001) CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: Adhesion is mediated by Ig-like domain 1. J Immunol 167 3668-3676.
168. M.S. Kalo, H.H. Yu and E.B. Pasquale (2001) In vivo tyrosine phosphorylation sites of activated ephrin-B1 and EphB2 from neural tissues. J Biol Chem 276 38940-38948.
169. R. Torres, B.L. Firestein, H.L. Dong, et al. (1998) PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 21 1453-1463.
170. D. Lin, G.D. Gish, Z. Songyang, et al. (1999) The carboxyl terminus of B class ephrins constitutes a PDZ binding motif. J Biol Chem 274 3726-3733.
171. K. Bruckner, L.J. Pablo Labrador J., P. Scheiffele, et al. (1999) Ephrin B ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22 511-524.
172. G.J. Della Rocca, T. Van Biesen, Y. Daaka, et al. (1997) Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors —Convergence of Gi-and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 272 19125-19132.
173. K. Kullander and R. Klein (2002) Mechanisms and function of Eph and ephrin signaling. Nature Rev Mol Cell Biol 3 475-486.
174. J. Holmberg and J. Frisen (2002) Ephrins are not only unattractive. Trends Neurosci 25 239-243.
175. V. Depaepe, N. Suarez-Gonzalez, A. Dufour, et al. (2005) Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 435 1244-1250.
176. R.H. Adams and R. Klein (2000) Eph receptors and ephrin ligands: Essential mediators of vascular development. Trends Cardiovasc Med 10 183-188.
177. N. Prevost, D. Woulfe, T. Tanaka, et al. (2002) Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci USA 99 9219-9224.
178. N. Prevost, D.S. Woulfe, M. Tognolini, et al. (2004) Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 103 1348-1355.
179. N. Prevost, D.S. Woulfe, H. Jiang, et al. (2005) Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 102 9820-9825.
180. M.G. Melaragno, Y.-W. Fridell and B.C. Berk (1999) The Gas6/Axl system: A novel regulator of vascular cell function. Trends Cardiovasc Med 9 250-253.
181. Y. Ishimoto and T. Nakano (2000) Release of a product of growth arrest-specific gene 6 from rat platelets. FEBS Lett 466 197-199.
182. A. Angelillo-Scherrer, P.G. De Frutos, C. Aparicio, et al. (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nature Med 7 215-221.
183. I. Balogh, S. Hafizi, J. Stenhoff, et al. (2005) Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 25 1280-1286.
184. T.N. Stitt, G. Conn, M. Gore, et al. (1995) The anticoagulation factor protein and its relative, Gas6, are ligands for the Tyro3/Axl family of receptor tyrosine kinases. Cell 80 661-670.
185. B.C. Varnum, C. Young, G. Elliott, et al. (1995) Axl receptor tyrosine kinase stimulated by the vitamin Kdependent protein encoded by the growth-arrest-specific gene 6. Nature 373 623-626.
186. C. Chen, Q. Li, A.L. Darrow, et al. (2004) Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol 24 1118-1123.
187. A. Angelillo-Scherrer, L. Burnier, N. Flores, et al. (2005) Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 115 237-246.
188. W.R. Gould, S.M. Baxi, R. Schroeder, et al. (2005) Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost 3 733-741.
189. J.A. Coppinger, G. Cagney, S. Toomey, et al. (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 2096-2104.
190. W. Bergmeier, C.L. Piffath, G. Cheng, et al. (2004) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 95 677-683.
191. T. Rabie, A. Strehl, A. Ludwig, et al. (2005) Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 280 14462-14468.
192. W. Bergmeier, T. Rabie, A. Strehl, et al. (2004) GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 91 951-958.
193. G. Stephens, Y. Yan, M. Jandrot-Perrus, et al. (2005) Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 105 186-191.
194. G. Berger, D.W. Hartwell and D.D. Wagner (1998) PSelectin and platelet clearance. Blood 92 4446-4452.
195. V. Henn, J.R. Slupsky, M. Gräfe, et al. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 591-594.
196. V. Henn, S. Steinbach, K. Buchner, et al. (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 1047-1054.
197. A. Hermann, B.H. Rauch, M. Braun, et al. (2001) Platelet CD40 ligand (CD40L) —subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 12 74-82.
198. R.M. Locksley, N. Killeen and M.J. Lenardo (2001) The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104 487-501.
199. F. Mach, U. Schonbeck, G.K. Sukhova, et al. (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394 200-203.
200. A.E. May, T. Kalsch, S. Massberg, et al. (2002) Engagement of glycprotein IIb/IIIa on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 2111-2117.
201. S. Danese and C. Fiocchi (2005) Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease. Crit Rev Immunol 25 103-122.
202. P. Andre, K.S. Prasad, C.V. Denis, et al. (2002) CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nature Med 8 247-252.
203. A.R. Crown, V. Leytin, A.F. Starkey, et al. (2003) CD154 (CD40 ligand) -deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates. J Thromb Haemost 1 850-852.
204. D.P. Inwald, A. McDowall, M.J. Peters, et al. (2003) CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92 1041-1048.
205. T. Kawasaki, M. Taniguchi, Y. Moritani, et al. (2005) Pharmacological properties of YM-254890, a specific G (alpha) q/11 inhibitor, on thrombosis and neointima formation in mice. Thromb Haemost 94 184-192.
206. J. Takasaki, T. Saito, M. Taniguchi, et al. (2004) A novel Galphaq/11-selective inhibitor. J Biol Chem 279 47438-47445.
207. P.G. Goekjian and M.R. Jirousek (1999) Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 6 877-903.
208. S. Narumiya, T. Ishizaki and M. Uehata (2000) Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325 273-284.
209. J.G. White, M. Krumwiede and G. Escolar (1999) EDTA induced changes in platelet structure and function: Influence on particle uptake. Platelets 10 327-337.
210. L.F. Brass, R.R. Vassallo Jr., E. Belmonte, et al. (1992) Structure and function of the human platelet thrombin receptor: Studies using monoclonal antibodies against a defined epitope within the receptor N-terminus. J Biol Chem 267 13795-13798.
211. H. Ishihara, A.J. Connolly, D. Zeng, et al. (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386 502-508.
212. T.R. Faruqi, E.J. Weiss, M.J. Shapiro, et al. (2000) Structure-function analysis of protease-activated receptor 4 tethered ligand peptides —Determinants of specificity and utility in assays of receptor function. J Biol Chem 275 19728-19734.
213. D.C.B. Mills (1996) ADP receptors on platelets. Thromb Haemost 76 835-856.
214. C. Gachet, B. Hechler, C. Léon, et al. (1997) Activation of ADP receptors and platelet function. Thromb Haemost 78 271-275.
215. M. Hirata, Y. Hayashi, F. Ushikubi, et al. (1991) Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349 617-620.
216. K. Hanasaki and H. Arita (1988) Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists. Biochem Pharmacol 37 3923-3929.
217. L. Furci, D.J. Fitzgerald and G.A. Fitz Gerald (1991) Heterogeneity of prostaglandin H2/thromboxane A2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 258 74-81.
218. B.K. Kobilka, H. Matsui, T.S. Kobilka, et al. (1987) Cloning, sequencing, and expression of the gene coding for the human platelet alpha2-adrenergic receptor. Science 238 650-656.
219. K. Inaba, Y. Umeda, Y. Yamane, et al. (1988) Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Clin Endocrinol (Oxf) 29 377-386.
220. W. Siess, M. Stifel, H. Binder, et al. (1986) Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. Biochem J 233 83-91.
221. D.G. Bichet, M.-F. Arthus, J.N. Barjon, et al. (1987) Human platelet fraction arginine-vasopressin: Potential physiological role. J Clin Invest 79 881-887.
222. D. Vittet, B. Cantau, M.-N. Mathieu, et al. (1988) Properties of vasopressin-activated human platelet high affinity GTPase. Biochem Biophys Res Commun 154 213-218.
223. Z. Honda, M. Nakamura, I. Miki, et al. (1991) Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349 342-346.
224. W. Chao and M.S. Olson (1993) Platelet-activating factor: Receptors and signal transduction. Biochem J 292 617-629.
225. M.A. Kowalska, J. Ratajczak, J. Hoxie, et al. (1999) Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: Determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 104 220-229.
226. M.A. Kowalska, M.Z. Ratajczak, M. Majka, et al. (2000) Stromal cell-derived factor-1 and macrophage-derived chemokine: two chemokines that activate platelets. Blood 96 50-57.
227. J.R. Vane and R.M. Botting (1995) Pharmacodynamic profile of prostacyclin. Am J Cardiol 75 3A-10A.
228. A.W. Gagnon, D.R. Manning, L. Catani, et al. (1991) Identification of Gzalpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes. Blood 78 1247-1253.
229. Lounsbury K.M., Casey P. J., Brass L. F. and Manning D. R., Phosphorylation of GZ in human platelets: Selectivity and site of modification. J Biol Chem, pp. 22051-22056.
230. K. Carlson, L.F. Brass and D.R. Manning (1989) Thrombin and phorbol esters cause the selective phosphorylation of a G protein other than Gi in human platelets. J Biol Chem 264 13298-13305.
231. L.F. Brass, J.A. Hoxie and D.R. Manning (1993) Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 70 217-223.
232. A. Shenker, P. Goldsmith, C.G. Unson, et al. (1991) The G protein coupled to the thomboxane A2 receptor in human platelets is a member of the novel Gq family. J Biol Chem 266 9309-9313.
233. G. Van Willigen, J. Donath, E.G. Lapetina, et al. (1995) Identification of alpha-subunits of trimeric GTP-binding proteins in human platelets by RT-PCR. Biochem Biophys Res Commun 214 254-262.
234. A.N. Giesberts, M. Van Ginneken, G. Gorter, et al. (1997) Subcellular localization of alpha-subunits of trimeric Gproteins in human platelets. Biochem Biophys Res Commun 234 439-444.
235. S. Tenailleau, J. Corre and S. Hermouet (1997) Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation. Exp Hematol 25 927-934.
236. A.M. Aragay and M.W. Quick (1999) Functional regulation of Galpha16 by protein kinase C. J Biol Chem 274 4807-4815.
237. S. Offermanns, Y.H. Hu and M.I. Simon (1996) Galpha12 and Galpha13 are phosphorylated during platelet activation. J Biol Chem 271 26044-26048.
238. K.L. Kelleher, K.I. Matthael and I.A. Hendry (2001) Targeted disruption of the mouse GZ-alpha gene: A role for GZ in platelet function? Thromb Haemost 85 529-532.
239. I. Davignon, M.D. Catalina, D. Smith, et al. (2000) Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice. Mol Cell Biol 20 797-804.
240. S. Offermanns, V. Mancino, J.-P. Revel, et al. (1997) Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275 533-536.
241. A.L. Darrow, W.P. Fung-Leung, R.D. Ye, et al. (1996) Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost 76 860-866.
242. J.-E. Fabre, M. Nguyen, A. Latour, et al. (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nature Med 5 1199-1202.